Cargando…
Increased GM‐CSF‐producing NCR(‐) ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel disease
OBJECTIVES: Inflammatory bowel disease (IBD) is characterised by dysregulated mucosal immune responses associated with genetic, environmental and microbial factors. Recent therapies targeting key inflammatory mediators such as tumor necrosis factor (TNF)‐α emphasise the importance of innate immunity...
Autores principales: | Chang, Yuna, Kim, Ju Whi, Yang, Siyoung, Chung, Doo Hyun, Ko, Jae Sung, Moon, Jin Soo, Kim, Hye Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264747/ https://www.ncbi.nlm.nih.gov/pubmed/34262760 http://dx.doi.org/10.1002/cti2.1311 |
Ejemplares similares
-
Interactions between NCR(+)ILC3s and the Microbiome in the Airways Shape Asthma Severity
por: Ham, Jongho, et al.
Publicado: (2021) -
ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation
por: Pearson, Claire, et al.
Publicado: (2016) -
NCR negative group 3 innate lymphoid cell (NCR(−)ILC3) participates in abnormal pathology of lung in cigarette smoking‐induced COPD mice
por: Chu, Shuyuan, et al.
Publicado: (2023) -
Runx3 Mediates Resistance to Intracellular Bacterial Infection by Promoting IL12 Signaling in Group 1 ILC and NCR+ILC3
por: Yin, Shengxia, et al.
Publicado: (2018) -
Neutrophil GM-CSF signaling in inflammatory bowel disease patients is influenced by non-coding genetic variants
por: Venkateswaran, Suresh, et al.
Publicado: (2019)